In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

Dear A.K.: Ogilvie syndrome is acute pseudo-obstruction of the colon. It is considered pseudo-obstruction because it looks ...

In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked attenuation of kidney function loss, suggesting a potential disease-modifying e ...

Pediatric kidney disease requires early diagnosis and specialized care to support growth, development, and long-term health.

A new meta-analysis further supports the previously reported link between kidney stones and an increased risk for kidney ...

Diabetic kidney disease affects a growing proportion of people with diabetes and remains the leading cause of end-stage renal ...

As the health care delivery landscape continues to evolve, the need to advocate for policies that affect patients and the ...

Boehringer Ingelheim has unveiled its second kidney-focused collaboration in recent weeks, this time penning a ...